Kidney Disease Protection on Steroids – Clinical Case Review

A middle-aged adult describes ten years of blasting and cruising anabolic steroids with ongoing fatigue. Poor libido and erectile dysfunction are reported despite continued hormone use. The case includes urinary symptoms that later lead to evaluation for a urethral stricture. Current dosing is described as testosterone cypionate at a very high concentration with frequent injections. Oxandrolone, often called Anavar, is taken on training days at doses described as sixty to eighty milligrams. Vital signs repeatedly show blood pressure in the 140s over the mid 90s. Early lab review includes HDL around twenty, LDL around one hundred twenty four, and liver enzymes in the mid sixties.

Kidney concern becomes central when chemistry results show blood urea nitrogen near sixteen and creatinine about 1.39. Proteinuria is emphasized as a major warning sign because it signals stress on kidney filters. Frequent use of nonsteroidal anti-inflammatory medication is described, including prescription Mobic taken several times weekly. The discussion highlights that high blood pressure plus NSAID exposure can accelerate kidney damage. Follow-up testing is framed around repeat urinalysis, quantitative urine protein measures, and trend monitoring over time. Muscular body size is noted as a reason creatinine can look higher, so context matters. Clinical interpretation still treats persistent protein leakage as a red flag needing urgent attention.

The likely pattern is discussed as a glomerular problem, with focal segmental glomerulosclerosis raised as a classic possibility. Referral to a nephrologist is recommended so specialized testing and kidney-protective therapy can be coordinated. An ACE inhibitor is mentioned as a tool that can lower pressure and reduce urine protein. Risk reduction also includes lowering steroid exposure, avoiding risky drug stacking, and correcting unsafe dosing habits. Counseling focuses on staying consistent with medical follow-up rather than abrupt withdrawal decisions. The plan stresses that protecting kidneys requires controlling blood pressure, stopping unnecessary NSAIDs, and monitoring urine findings. A long competitive career is presented as possible when harm reduction decisions remain steady and evidence-based.